Feature

The Hunt for New Checkpoint Inhibitors

Amgen is using human genetics and cutting-edge biology to search for new checkpoint targets that will work in more types of cancer and more patients.

About Us

Amgen is a pioneer in the science of using living cells to make biologic medicines.

Subscribe for the latest from Amgen Science.

System error message. Lorem ipsum.
I authorize Amgen and its contractors to use my email address and provide me with updates, informational material, and/or contact me about Amgen Science. I understand that my email address will not be used for any other purposes. I understand that receiving these communications is optional and free and that I have the ability to opt out at anytime. For more information, please see the Amgen privacy policy.